DK1968651T3 - Stabiliserede sammensætninger og fremgangsmåder til radioaktiv mærkning af lægemidler med alfa-partikelemittere - Google Patents
Stabiliserede sammensætninger og fremgangsmåder til radioaktiv mærkning af lægemidler med alfa-partikelemittereInfo
- Publication number
- DK1968651T3 DK1968651T3 DK06850596.5T DK06850596T DK1968651T3 DK 1968651 T3 DK1968651 T3 DK 1968651T3 DK 06850596 T DK06850596 T DK 06850596T DK 1968651 T3 DK1968651 T3 DK 1968651T3
- Authority
- DK
- Denmark
- Prior art keywords
- drugs
- alpha
- methods
- radioactive labeling
- stabilized compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C07B63/04—Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75237005P | 2005-12-22 | 2005-12-22 | |
| PCT/US2006/048811 WO2007120251A2 (en) | 2005-12-22 | 2006-12-22 | Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1968651T3 true DK1968651T3 (da) | 2013-06-17 |
Family
ID=38609971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06850596.5T DK1968651T3 (da) | 2005-12-22 | 2006-12-22 | Stabiliserede sammensætninger og fremgangsmåder til radioaktiv mærkning af lægemidler med alfa-partikelemittere |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8337810B2 (da) |
| EP (1) | EP1968651B1 (da) |
| JP (1) | JP5264500B2 (da) |
| CA (1) | CA2634666C (da) |
| DK (1) | DK1968651T3 (da) |
| WO (1) | WO2007120251A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2843625T3 (es) | 2014-06-18 | 2021-07-19 | Alpha Therapy Solutions Ab | Plataforma de proceso automático para la producción de radiofármacos marcados con astatina-211 [At-211] |
| EP3600453A1 (en) * | 2017-03-30 | 2020-02-05 | Duke University | Radiolabeled biomolecules and their use |
| EP3663307A4 (en) * | 2017-08-04 | 2021-03-24 | Osaka University | MANUFACTURING PROCESS FOR RADIOACTIVELY MARKED ARYL COMPOUND |
| WO2019131998A1 (ja) * | 2017-12-29 | 2019-07-04 | 国立大学法人大阪大学 | アスタチン溶液及びその製造方法 |
| CN111463110B (zh) * | 2020-04-15 | 2023-05-09 | 武汉华星光电半导体显示技术有限公司 | 基于溶液法的ito薄膜的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826672A (en) * | 1985-06-07 | 1989-05-02 | President And Fellows Of Harvard College | Astatinated organic compounds |
| US5262175A (en) * | 1989-05-10 | 1993-11-16 | Solanki Kishor K | Stabilization of radiopharmaceutical compositions |
| US5219556A (en) | 1990-07-09 | 1993-06-15 | Mallinckrodt Medical, Inc. | Stabilized therapeutic radiopharmaceutical complexes |
| EP1311301A2 (en) * | 2000-07-06 | 2003-05-21 | Bristol-Myers Squibb Pharma Company | Stable radiopharmaceutical compositions and methods for preparation thereof |
-
2006
- 2006-12-22 JP JP2008547553A patent/JP5264500B2/ja active Active
- 2006-12-22 DK DK06850596.5T patent/DK1968651T3/da active
- 2006-12-22 CA CA2634666A patent/CA2634666C/en not_active Expired - Fee Related
- 2006-12-22 WO PCT/US2006/048811 patent/WO2007120251A2/en active Application Filing
- 2006-12-22 US US12/158,186 patent/US8337810B2/en active Active
- 2006-12-22 EP EP06850596A patent/EP1968651B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5264500B2 (ja) | 2013-08-14 |
| US8337810B2 (en) | 2012-12-25 |
| JP2009521469A (ja) | 2009-06-04 |
| CA2634666C (en) | 2015-05-26 |
| EP1968651A2 (en) | 2008-09-17 |
| WO2007120251A3 (en) | 2007-12-27 |
| CA2634666A1 (en) | 2007-10-25 |
| WO2007120251A2 (en) | 2007-10-25 |
| EP1968651A4 (en) | 2009-10-21 |
| EP1968651B1 (en) | 2013-03-13 |
| US20090304585A1 (en) | 2009-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1940351T3 (da) | Formulering af småmolekylære lægemidler med langvarig frigørelse | |
| DK2254590T3 (da) | Fremgangsmåder og præparater til oral administration af insulin | |
| DK3438131T3 (da) | Oligosaccharidmodifikation og mærkning af proteiner | |
| SMP200700023B (it) | Dispositivi e metodi per iniezioni di medicinali | |
| DK1501485T3 (da) | Tablet med höjt indhold af aktivt stof | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| DK1986679T3 (da) | Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof | |
| DK3345625T3 (da) | Farmaceutisk sammensætning og indgivelser deraf | |
| DK1868454T3 (da) | Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning | |
| DK1856374T3 (da) | Sammensætning og fremgangsmåde til fremstilling af et støttemiddel | |
| DK1942967T3 (da) | Fremgangsmåde til dosering af medikamenter | |
| DK2114924T3 (da) | Co-krystaller og farmaceutiske sammensætninger omfattende disse | |
| DK3461503T3 (da) | Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder | |
| DK3782612T3 (da) | Orale formuleringer af cytidinanaloger og fremgangsmåder til anvendelse deraf | |
| DK2330527T3 (da) | System og fremgangsmåde til bestemmelse af medicinindgivelsesinformation | |
| DK2220116T3 (da) | Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza | |
| DK3081215T3 (da) | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin | |
| DK2478916T3 (da) | Influenzavacciner indeholdende hæmagglutinin og matrixproteiner | |
| DK1896034T3 (da) | Mikroniserede tanaproget-sammensætninger og fremgangsmåder til fremstilling af disse | |
| DK1922309T3 (da) | N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf | |
| DK1862158T3 (da) | Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf | |
| DK2046373T3 (da) | Krystalliseret oxalatdecarboxylase og fremgangsmåder til anvendelse | |
| BRPI0819232A2 (pt) | composto heterocíclico e composição farmacêutica do mesmo | |
| DK2617714T3 (da) | Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf | |
| BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo |